---
title: "LIFT: Telemedicine Breastfeeding Support"
nct_id: NCT03901833
overall_status: COMPLETED
phase: NA
sponsor: University of California, Davis
study_type: INTERVENTIONAL
primary_condition: Breastfeeding
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03901833.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03901833"
ct_last_update_post_date: 2024-11-12
last_seen_at: "2026-05-12T06:42:20.885Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# LIFT: Telemedicine Breastfeeding Support

**Official Title:** Telemedicine Breastfeeding Support Following Late Preterm Delivery: A Randomized Controlled Trial

**NCT ID:** [NCT03901833](https://clinicaltrials.gov/study/NCT03901833)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 56
- **Lead Sponsor:** University of California, Davis
- **Collaborators:** National Institutes of Health (NIH)
- **Conditions:** Breastfeeding
- **Start Date:** 2019-07-24
- **Completion Date:** 2024-03-29
- **CT.gov Last Update:** 2024-11-12

## Brief Summary

The central hypothesis guiding this project is that tailored breastfeeding support, that leverages easily accessible telemedicine technologies, can improve breastfeeding outcomes among late preterm dyads. The long-term goals of this project are to improve maternal and child health and reduce health disparities by designing and implementing evidence-based interventions to improve breastfeeding outcomes for this challenging patient population. This study seeks to identify lactation support practices that improve breastfeeding duration and to test the effect of telemedicine breastfeeding support on breastfeeding duration, among the nearly one in ten mothers who deliver late preterm (34-37 6/7 weeks), as this subpopulation of mothers faces the highest rates of premature breastfeeding cessation

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* maternal age 18-49 years
* late preterm delivery (34-37 6/7 weeks)
* enrollment up to 1 week postpartum
* breastfeeding initiated
* access to a smartphone, tablet, or laptop computer in their home

Exclusion Criteria:

* incarceration
* inability to communicate in English
* infant with medical condition compromising breastfeeding (e.g. cleft lip and/or palate).
```

## Arms

- **Telemedicine Support** (EXPERIMENTAL) — Weekly telemedicine breastfeeding support visits for four weeks, delivered via telemedicine
- **Control** (PLACEBO_COMPARATOR) — Standard of care

## Interventions

- **Telemedicine Support** (BEHAVIORAL) — Telemedicine intervention
- **Standard of Care** (OTHER) — Standard of Care

## Primary Outcomes

- **Experience** _(time frame: One month post-enrollment)_ — Mean score on a modified, 16-item Interactive Telehealth Satisfaction Scale \>48 (corresponding to better than neutral on a 5 point Likert scale, 16 questions).

## Secondary Outcomes

- **Time to cessation** _(time frame: Monthly up to 12 months)_
- **Exclusive breastfeeding cessation** _(time frame: Monthly up to 12 months)_
- **Breastfeeding at 3 months** _(time frame: 3 months)_
- **Exclusive breastfeeding** _(time frame: 3 months)_
- **Individual satisfaction questions** _(time frame: 1 month post enrollment)_

## Locations (1)

- University of California-Davis, Sacramento, California, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university of california-davis|sacramento|california|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03901833.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03901833*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*